What does business segments — PP&E (net) mean?

The net book value of tangible assets used in the pharmaceutical segment, including laboratory facilities, manufacturing equipment, and office infrastructure. This metric tracks the capital intensity of the business and the scale of physical assets required to support clinical and commercial operations.

Kiniksa Pharmaceuticals International, plc KNSA Business Segments — PP&E (Net)

Similar metrics at other companies

LLYPP&E (Net)

$26.54B+43.7%

BMYPP&E (Net)

$7.66B+6.2%

ASHLife Sciences — PP&E (Net)

$468M—

AXSMPP&E (Net)

$567K-26.6%

BTSGPP&E (Net)

$201.89M+13.9%

CLMTPerformance Brands — PP&E (Net)

$28.3M-8.7%

Other financials

Income statement

See full

Revenue$214.3M+55.5%

Gross profit$193.5M+61.3%

Operating income$29.3M+121%

Net income$22.6M+165%

EPS (diluted)$0.27+145%

Balance sheet

See full

Cash & equivalents$190.0M+20.9%

Total debt$9.0M-9.0%

Total equity$605.7M+32.4%

Total assets$825.3M+37.7%

Cash flow

See full

Operating cash flow$50.2M+125%

CapEx$161.0K+62.6%

Free cash flow$50.0M+125%

Valuation

See full

Market cap$4.58B+128%

Profitability

See full

Gross margin89.3%+3.5pp

Operating margin12.4%+10.2pp

Net margin9.7%+7.6pp

FCF margin21.8%+12.2pp

Returns & leverage

See full

Return on equity13.7%+11.3pp

Debt / equity0×0.0×

Current ratio3.8×+0.1×

Where this comes from

Reported directly by Kiniksa Pharmaceuticals International, plc in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kiniksa Pharmaceuticals International, plc's business segments — pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Kiniksa Pharmaceuticals International, plc's business segments — PP&E (net)?: Kiniksa Pharmaceuticals International, plc (KNSA) reported business segments — PP&E (net) of $1.99M in Q1 2026.
What does business segments — PP&E (net) mean?: The net book value of tangible assets used in the pharmaceutical segment, including laboratory facilities, manufacturing equipment, and office infrastructure. This metric tracks the capital intensity of the business and the scale of physical assets required to support clinical and commercial operations.